Medical/Pharmaceuticals
Menarini Asia-Pacific partners with Pharmacosmos to expand its reach of MonoFer® to Singapore and Malaysia
SINGAPORE, June 19, 2024 /PRNewswire/ -- Menarini Asia-Pacific (Menarini) today announced that it has expanded its partnership with Pharmacosmos A/S (Pharmacosmos), to include exclusive rights to commercialiseMonoFer® (ferric derisomaltose) in Singapore and Malaysia. This builds upon the successf...
2024-06-19 09:43
2876
YolTech and KACTUS Join Forces to Propel Innovative DNA editing system in Greater China
Strategic Partnership to Advance Gene Editing Technologies in Biomedical Applications SHANGHAI, June 18, 2024 /PRNewswire/ -- YolTech, a clinical-stage biopharmaceutical company specializing in mRNA-LNP delivery forin vivo gene editing therapies, has partnered with KACTUS, a leading developer se...
2024-06-19 09:00
2245
Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL Registry
Clinical investigators complete record enrollment in real-world Registry, HEAL (An All-comers Registry of the MicroStent PeripHeral Vascular StEnt in subjects with PeripherAl ArteriaL Disease) WILMINGTON, Mass., June 19, 2024 /PRNewswire/ -- Micro Medical Solutions -- Micro Medical Solutions, a ...
2024-06-19 07:11
2784
Singleron Biotechnologies partners with the Human Cell Atlas (HCA) to enhance access to single cell analysis globally
COLOGNE, Germany, June 18, 2024 /PRNewswire/ -- Singleron Biotechnologies announced a partnership with the Human Cell Atlas (HCA) to help accelerate the adoption of single cell sequencing globally. Singleron will facilitate access to its single cell analysis platform via the HCA network, by provi...
2024-06-18 21:00
2567
Prenetics Announces First Quarter 2024 Financial Results
First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S. Consumer Healthcare Market Reaffirms 2024 Revenue Range of US$33 million to US$36 million LOS ANGELES, June 18, 2024 /PRNewswire/ -- Prenetics Global Limit...
2024-06-18 20:30
4962
Qilian International Holding Group Limited Announces 1 for 5 Reverse Share Split
CHENGDU, China, June 18, 2024 /PRNewswire/ -- Qilian International Holding
Group Limited (NASDAQ:QLI
2024-06-18 20:30
4938
Pie Medical Imaging announces enrollment completion of the FASTIII clinical trial
MAASTRICHT, Netherlands, June 18, 2024 /PRNewswire/ -- Pie Medical Imaging, a global leader in cardiac imaging, announced thecompletion of enrollment in FASTIII, a multi-center randomized clinical trial, which investigates the use of angiography-based vessel fractional flow reserve (CAAS vFFR) in...
2024-06-18 18:00
2753
Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults
-- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralizing antibody titers in older adults up to approximately 7,900 IU/mL (up to 8-fold increase) and approximately 46,700 IU/mL (up to 11-fold increase), respectively -- -- Favorable safety & reactogenicity profile comparable to sali...
2024-06-18 17:41
3861
Thermo Fisher Scientific, National University Hospital and Mirxes Collaborate to Enhance Access to Advanced Genomic Testing for Early Cancer Detection in Singapore
Partnership Aims to Personalize Cancer Care Tailored to the Needs of Southeast Asian Population to Provide Better Individualized Care SINGAPORE, June 18, 2024 /PRNewswire/ -- To increase patient access to affordable, advanced genomic testing for cancer inSingapore, Thermo Fisher Scientific Inc.,...
2024-06-18 16:46
7382
Diplomatic Envoys to China Visit Fosun: Appreciating Oriental Lifestyle Aesthetics and Seeking Opportunities for Business Cooperation
SHANGHAI, June 18, 2024 /PRNewswire/ -- Over 40 guests, including 10 ambassadors toChina, 8 consuls general and other senior diplomats from 26 countries, visited Fosun on 14 June. The delegation toured along the Grand Yuyuan. From the intangible cultural heritage of the Old City of Shanghai to t...
2024-06-18 12:53
4496
Live from EHA 2024 | Ascentage Pharma Releases Updated Data of Lisaftoclax in Patients with R/R MM and AL Amyloidosis Highlighting Marked Improvement in ORR
SUZHOU, China and ROCKVILLE, Md., June 18, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data of the Bcl-2 inh...
2024-06-18 12:43
3283
Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including Encouraging Data from US Study in CML and Ph+ ALL
SUZHOU, China and ROCKVILLE, Md., June 18, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that updated results from three studies of olverem...
2024-06-18 12:23
3076
Gan & Lee Pharmaceuticals to Present Groundbreaking Data on Three Innovative Products at the American Diabetes Association's 84th Scientific Sessions
* A phase 1b/2a trial evaluated once- and bi-weekly GZR18, a novel GLP-1 analog, in Chinese subjects with obesity/overweight * Pre-clinical studies evaluated the molecular and pharmacological properties of GZR4, an investigational once-weekly insulin analog * Pre-clinical studies evaluated ...
2024-06-18 12:13
3538
Xinhua Silk Road: Diverse TCM-related cultural activities help south China city boost big health industry
BEIJING, June 18, 2024 /PRNewswire/ -- By staging diverse traditional Chinese
medicine (TCM)-related cultural activities, Yulin, a southChina-situated city,
revved up development of local big health industry recently.
2024-06-18 11:57
3399
High-Quality Healthcare Without the High Costs: Shenzhen TreeENT Attracts Numerous Hong Kong Clients with Outstanding Value
HONG KONG, June 18, 2024 /PRNewswire/ -- With the continuous improvement of mainlandChina's healthcare standards, advantages such as expert consultations, no long waiting times, and affordable costs have attracted manyHong Kong residents to seek medical care in Shenzhen. Recently, Shenzhen TreeEN...
2024-06-18 11:43
2532
ReviR Therapeutics Reaches Milestone in Novel Splicing Therapy Development in Collaboration with Asieris Pharmaceuticals
BRISBANE, Calif. and SHANGHAI, June 17, 2024 /PRNewswire/ -- ReviR Therapeutics, a biotechnology company specializing in the development of small molecule RNA splicing modulators for neurogenetic diseases and oncology indications, and Asieris Pharmaceuticals, a global biopharmaceutical leader in ...
2024-06-17 22:00
2736
CardioFlow's VitaFlow Liberty™ Granted EU CE-MDR Mark, Advancing Global Expansion Roadmap
SHANGHAI, June 17, 2024 /PRNewswire/ -- MicroPort® CardioFlow Medtech Corporation (CardioFlow) (Stock Code: 02160.HK) recently announced that its self-developed second-generation transcatheter aortic valve implantation (TAVI) device, the VitaFlowLibertyTM Transcatheter Aortic Valve and Retrievabl...
2024-06-17 21:32
2464
Noul Participates in a Malaria Project Initiated by U.S. CDC with Kenya Medical Research Institute
* Gain attention as an alternative technology to the malaria HRP-2/3 gene deletion problem inAfrica * Prepare a bridgehead to enter the U.S. market by securing a credible reference YONGIN, South Korea, June 17, 2024 /PRNewswire/ -- On-Device AI healthcare company, Noul, announced that it will...
2024-06-17 21:00
2991
Peijia Medical Reports Audited 2023 Financial Results and Resumes Trading
HONG KONG, June 17, 2024 /PRNewswire/ -- Peijia Medical (HKG:9996), a leading Chinese domestic player in the high-growth transcatheter valve therapeutic and neurointerventional procedural medical device markets, announced the publication of its audited financial results for the year endedDecember...
2024-06-17 20:30
4014
Leads Biolabs Unveils Preclinical Data on LBL-047, a Novel, First-In-Class Long-Acting TACI/Anti-BDCA2 Bispecific Antibody Fusion Protein in an Oral Presentation at EULAR 2024 Congress
NANJING, China, June 17, 2024 /PRNewswire/ -- At the recent European League Against Rheumatism (EULAR) Congress inVienna, Austria, Nanjing Leads Biolabs Co., Ltd. (Leads Biolabs) delivered an oral presentation on its highly innovative therapeutic candidate LBL-047. LBL-047 is a first-in-class, l...
2024-06-17 18:00
1967
Week's Top Stories
Most Reposted
Never Miss a Message: Agoda's Customer Support Now Travels With You
[Picked up by 328 media titles]
2026-02-24 12:00
HBX Group and Traveloka expand strategic partnership to deepen APAC supply and accelerate global distribution
[Picked up by 309 media titles]
2026-02-26 09:30
Amadeus acquires SkyLink to accelerate the deployment of AI in travel
[Picked up by 307 media titles]
2026-02-26 19:57
Klook and Osaka Convention & Tourism Bureau sign MoU to advance inbound tourism and foster socio-economic development throughout Osaka Prefecture
[Picked up by 302 media titles]
2026-02-24 16:13
SMU and Fudan Launch Region's First Tech-Focused DBA
[Picked up by 298 media titles]
2026-03-02 09:15Most Read
NYSE Content Update: AI Data Platform DDN Appoints Guido Torrini as Finance Chief
2026-02-24 22:08
6664
